2020Advanced NanoBiomed ResearchOpen access

Injectable Drug Delivery System Based on In Situ Self‐Assembly of Liquid Star Polyethylene Glycol–Poly(lactic‐co‐glycolic acid)

Bat‐hen Eylon, Alona Shagan, Ayelet Shabtay‐Orbach, Adi Gross, Boaz Mizrahi

Open full text 2 citations

Abstract

Particulate systems are widely used in biomedical applications, yet current systems are limited by their stability, complicated production processes, and the use of toxic excipients and cosolvents. Here, a new concept for an injectable nanocarrier system based on the in situ self‐assembled star polyethylene glycol (PEG)– poly(lactic‐co‐glycolic acid) (PLGA)/drug mixture is presented. The new injectable material is based on a neat (solvent‐free) liquid copolymer that self‐assembles after it is injected along with the drug to form a particulate delivery system. The nanocarriers’ formation rate and encapsulation capabilities of hydrophobic drugs can be fine‐tuned by changing the molecular weight of the PLGA segment. Furthermore, the starPEG–PLGA‐based system demonstrates potential as a drug carrier for hydrophobic drugs and shows biocompatibility with cell line culture.

About this research paper

What this paper is about

Particulate systems are widely used in biomedical applications, yet current systems are limited by their stability, complicated production processes, and the use of toxic excipients and cosolvents. Here, a new concept for an injectable nanocarrier system based on the in situ self‐assembled star polyethylene glycol (PEG)– poly(lactic‐co‐glycolic acid) (PLGA)/drug mixture is presented. The new injectable material is based on a neat (solvent‐free) liquid copolymer that self‐assembles after it is injected along with the drug to form a particulate delivery system. The nanocarriers’ formation rate and encapsulation capabilities of hydrophobic drugs can be fine‐tuned by changing the molecular weight of the PLGA segment. Furthermore, the starPEG–PLGA‐based system demonstrates potential as a drug carrier for hydrophobic drugs and shows biocompatibility with cell line culture.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Particulate systems are widely used in biomedical applications, yet current systems are limited by their stability, complicated production processes, and the use of toxic excipients and cosolvents. Here, a new concept for an injectable nanocarrier system based on the in situ self‐assembled star polyethylene glycol (PEG)– poly(lactic‐co‐glycolic acid) (PLGA)/drug mixture is presented. The new injectable material is based on a neat (solvent‐free) liquid copolymer that self‐assembles after it is injected along with the drug to form a particulate delivery system. The nanocarriers’ formation rate and encapsulation capabilities of hydrophobic drugs can be fine‐tuned by changing the molecular weight of the PLGA segment. Furthermore, the starPEG–PLGA‐based system demonstrates potential as a drug carrier for hydrophobic drugs and shows biocompatibility with cell line culture.

Key concepts: PLGA, Nanocarriers, Polyethylene glycol, Biocompatibility, Drug delivery, Glycolic acid, Lactic acid, Chemical engineering

Related papers

Back to paper searchBrowse research topicsOriginal source
Injectable Drug Delivery System Based on In Situ Self‐Assembly of Liquid Star Polyethylene Glycol–Poly(lactic‐co‐glycolic acid) — Research Paper | ScholarLens